Results 151 to 160 of about 46,872 (214)

Investigation of intake pattern of SGLT2 inhibitors among shift workers with diabetes: a crossover study. [PDF]

J Pharm Health Care Sci
Torii-Goto A, Shiomi K, Murase M, Yoshioka H, Ito J, Yoshikawa M.   +5 more
europepmc   +1 more source

Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol) [PDF]

core   +1 more source

Benefits of SGLT2 inhibitors in patients with diabetes and advanced chronic kidney disease - where have we gone so far? [PDF]

Front Clin Diabetes Healthc
Duni A, Tsavourelou P, Triantafyllidou M, Gkika L, Georgopoulos C, Stamellou E, Kitsos A, Dounousi E.   +7 more
europepmc   +1 more source

Association between SGLT2 inhibitors and recurrence of cerebrovascular events in patients with type 2 diabetes: A population-based cohort study. [PDF]

Diab Vasc Dis Res
Kim MH, Gil JY, Min KH, Kim JH, Park JH, Park S, Han JM, Lee KE.   +7 more
europepmc   +1 more source

Effect of SGLT2 Inhibitors on Atrial Fibrillation in Patients With Type 2 Diabetes With Dilated Cardiomyopathy: A Cohort Study. [PDF]

Cardiovasc Ther
Wang J, Qi S, Chen S, Yu H.
europepmc   +1 more source

SGLT2 Inhibitors: From Structure-Effect Relationship to Pharmacological Response. [PDF]

Int J Mol Sci
Mateoc T, Dumitrascu AL, Flangea C, Puscasiu D, Vlad T, Popescu R, Marina C, Vlad DC.   +7 more
europepmc   +1 more source

Erythrocytosis and thromboembolic risks associated with SGLT2 inhibitors in type 2 diabetes. [PDF]

Sci Rep
Chen YH, Hsieh TYJ, Sun AY, Chen K, Choi E, Rastogi N, Cheng J, Wei JC, Lee CH.   +8 more
europepmc   +1 more source

Discordance Between HbA1c and Glucose Management Indicator in People With Type 2 Diabetes Treated With SGLT2 Inhibitors. [PDF]

J Diabetes Sci Technol
Hayashi A, Tsukushi T, Shinohara R, Sogabe H, Tsuji S, Shimizu N, Miyatsuka T.   +6 more
europepmc   +1 more source

Multiple Effects of SGLT2 Inhibitors

JMA Journal
openaire   +2 more sources